Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.
暂无分享,去创建一个
K. Manova | M. Gonen | Dajun Yang | G. Marcucci | J. Holmlund | O. O’Connor | M. Heaney | L. Leopold | J. Gardner | L. Paoluzzi | M. Sorensen | Jill Mastrella